Literature DB >> 9142381

Extended surgery--left upper abdominal exenteration plus Appleby's method--for type 4 gastric carcinoma.

H Furukawa1, M Hiratsuka, T Iwanaga, S Imaoka, O Ishikawa, T Kabuto, Y Sasaki, M Kameyama, H Ohigashi, S Nakamori, T Yasuda.   

Abstract

BACKGROUND: The prognosis after surgical treatment for type 4 gastric cancer, including linitis plastica, remains poor. The most frequent recurrence mode is retroperitoneal involvement. To remove the tumor and microinvasion surrounding the stomach, extended surgery, left upper abdominal exenteration plus the Appleby's method (LUAE + Apl), has been performed for type 4 cancers since 1983. PATIENTS AND METHODS: A total of 54 patients with type 4 cancer underwent extended surgery (LUAE + Apl) over the past 11 years. In the LUAE + Apl surgical procedure, the whole stomach, pancreas body and tail, spleen, gallbladder, transverse colon, and left adrenal were removed en bloc. The results of this treatment are reported and the most beneficial application of this procedure (group A) is evaluated and compared with findings in similar patients who underwent common surgery between 1973 and 1983 (group B).
RESULTS: As postoperative complications, pancreatic fistula (30%; control 19%), liver dysfunction (15%; 14%), anastomosis failure (6%; 9%), and infection (4%; 1%) were observed (NS). In group A, one patient died of liver dysfunction and another of multiple organ failure due to major pancreatic fistula. In stage III, the 5-year survival rate of group A (40%) was better than that of group B (20%; p < 0.05). In stage IV, the 5-year survival rate of group A (5%; 3% in group B) was not improved.
CONCLUSION: LUAE + Apl improved the survival of patients with scirrhous cancer in stage III, but it was not effective for those in stage IV. To improve the survival of patients in stage IV, a new concept of treatment and supportive therapy needs to be used.

Entities:  

Mesh:

Year:  1997        PMID: 9142381     DOI: 10.1007/bf02306612

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study.

Authors:  Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Kazuo Inoue; Tatsuya Oda; Shinichiro Takahashi; Narikazu Boku; Atsushi Ohtsu; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

3.  Distribution of free cancer cells in the abdominal cavity suggests limitations of bursectomy as an essential component of radical surgery for gastric carcinoma.

Authors:  Yoshitaka Yamamura; Seiji Ito; Yoshinari Mochizuki; Hayao Nakanishi; Masae Tatematsu; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

Review 4.  The relevance of gastrointestinal fistulae in clinical practice: a review.

Authors:  M Falconi; P Pederzoli
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

5.  Clinicopathological analysis of Borrmann type IV gastric cancer.

Authors:  Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

Review 6.  The role of surgery in the current treatment of gastric carcinoma.

Authors:  Hiroshi Furukawa; Hiroshi Imamura; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

Review 7.  Recent results of therapy for scirrhous gastric cancer.

Authors:  Masahide Ikeguchi; Takanori Miyake; Tomoyuki Matsunaga; Manabu Yamamoto; Youji Fukumoto; Yosinori Yamada; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe; Shun-ichi Tsujitani
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

8.  Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experience.

Authors:  Rieko Nakamura; Yoshiro Saikawa; Norihito Wada; Masashi Yoshida; Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2007-08-20       Impact factor: 3.402

9.  Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment.

Authors:  M Schauer; M Peiper; J Theisen; W Knoefel
Journal:  Eur J Med Res       Date:  2011-01-27       Impact factor: 2.175

10.  Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis.

Authors:  Yifan Luo; Peng Gao; Yongxi Song; Jingxu Sun; Xuanzhang Huang; Junhua Zhao; Bin Ma; Yuan Li; Zhenning Wang
Journal:  World J Surg Oncol       Date:  2016-02-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.